RJT
DXCM icon

Raymond James Trust’s DexCom DXCM Stock Holding History

Raymond James Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$682K Sell
10,176
-16,602
-62% -$1.36M 0.01% 643
2024
Q2 		$3.04M Buy
26,778
+1,028
+4% +$130K 0.07% 229
2024
Q1 		$3.57M Buy
25,750
+3,651
+17% +$459K 0.09% 212
2023
Q4 		$2.74M Buy
22,099
+17,002
+334% +$1.74M 0.07% 238
2023
Q3 		$476K Sell
5,097
-764
-13% -$86.1K 0.01% 663
2023
Q2 		$753K Buy
5,861
+1,221
+26% +$148K 0.02% 500
2023
Q1 		$539K Sell
4,640
-318
-6% -$35.6K 0.02% 601
2022
Q4 		$562K Sell
4,958
-619
-11% -$68K 0.02% 556
2022
Q3 		$449K Sell
5,577
-250
-4% -$21.2K 0.02% 617
2022
Q2 		$435K Sell
5,827
-3,105
-35% -$283K 0.02% 634
2022
Q1 		$1.14M Buy
8,932
+268
+3% +$29.3K 0.04% 378
2021
Q4 		$1.16M Sell
8,664
-204
-2% -$29.3K 0.03% 388
2021
Q3 		$1.21M Buy
8,868
+172
+2% +$21.7K 0.04% 349
2021
Q2 		$928K Buy
8,696
+6,168
+244% +$592K 0.03% 424
2021
Q1 		$227K Sell
2,528
-20
-0.8% -$1.88K 0.01% 970
2020
Q4 		$235K Buy
2,548
+48
+2% +$4.29K 0.01% 878
2020
Q3 		$257K Sell
2,500
-112
-4% -$11.7K 0.01% 765
2020
Q2 		$264K Buy
+2,612
New +$234K 0.01% 722
2017
Q1 		– Sell
-13,644
Closed -$203K – 714
2016
Q4 		$203K Buy
+13,644
New +$242K 0.02% 637

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Raymond James Trust's DXCM Position: Q3 2024 in Review

Raymond James Trust reduced its DexCom (DXCM) stake by 62% in Q3 2024, selling an estimated $1.36M and leaving 10,176 shares worth $682K. The position accounts for 0.01% of the portfolio, ranked #643.

Raymond James Trust first reported a position in DXCM in Q4 2016 and has held it in 19 quarters since. The position peaked at $3.57M in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Raymond James Trust held 10,176 shares of DexCom worth $682K as of Q3 2024.
  • Raymond James Trust sold 16,602 DexCom shares in Q3 2024, an estimated $1.36M.
  • DexCom made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #643 holding.
  • Raymond James Trust first reported a position in DexCom in Q4 2016 and has held it in 19 quarters since.
  • Raymond James Trust's DexCom position peaked at $3.57M in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.